LUNGPulmonx Corp

Nasdaq pulmonx.com


$ 9.06 $ -0.26 (-2.79 %)    

Thursday, 16-May-2024 15:59:55 EDT
QQQ $ 451.64 $ -1.83 (-0.4 %)
DIA $ 399.14 $ -0.07 (-0.02 %)
SPY $ 528.49 $ -1.29 (-0.24 %)
TLT $ 92.06 $ -0.04 (-0.04 %)
GLD $ 220.06 $ -0.83 (-0.38 %)
$ 9.05
$ 9.28
$ 0.00 x 0
$ 0.00 x 0
$ 8.88 - $ 9.28
$ 7.11 - $ 14.84
266,215
na
360.09M
$ 1.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-pulmonx-lowers-price-target-to-15

Canaccord Genuity analyst Jon Young maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $16 to $15.

Core News & Articles
Market-Moving News May 2nd
05/02/2024 12:39:37

ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical...

 pulmonx-q1-2024-gaap-eps-036-beats-046-estimate-sales-18854m-beat-17893m-estimate

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.46) by 21...

 piper-sandler-reiterates-overweight-on-pulmonx-maintains-17-price-target

Piper Sandler analyst Jason Bednar reiterates Pulmonx (NASDAQ:LUNG) with a Overweight and maintains $17 price target.

 pulmonx-announces-appointment-of-mehul-joshi-as-chief-financial-officer-effective-april-3-2024

Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatment...

 pulmonx-announces-treatment-of-the-first-patient-with-the-aeriseal-system-in-convert-ii-pivotal-trial

AeriSeal System Shows Promise in Limiting Collateral Ventilation, Potentially Enabling a Greater Number of Severe COPD/Emphysem...

 analyst-ratings-for-pulmonx
Analyst Ratings For Pulmonx
02/23/2024 12:00:55

 why-etsy-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Etsy, Inc.

 pulmonx-q4-2023-gaap-eps-036-beats-042-estimate-sales-1928m-beat-1827m-estimate

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.42) by 14...

 earnings-scheduled-for-february-21-2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on...

 piper-sandler-maintains-overweight-on-pulmonx-lowers-price-target-to-13

Piper Sandler analyst Jason Bednar maintains Pulmonx (NASDAQ:LUNG) with a Overweight and lowers the price target from $17 to...

 canaccord-genuity-maintains-buy-on-pulmonx-lowers-price-target-to-12

Canaccord Genuity analyst William Plovanic maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $20 t...

 why-jetblue-airways-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptan...

 arista-networks-jinkosolar-repligen-shutterstock-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION